HemaSphere (May 2023)
P49 A REAL-WORLD RETROSPECTIVE-PROSPECTIVE ANALYSIS OF EFFICACY AND SAFETY OF COMBINED IXAZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: THE NORTHERN ITALY EXPERIENCE
- A. Furlan,
- M. Cea,
- R. Zambello,
- L. Pavan,
- M Galli,
- C. Clissa,
- S. Mangiacavalli,
- A. Cafro,
- S. Girlanda,
- F. Patriarca,
- C. Minotto,
- G. Bertoldero,
- G. Barilà,
- A. Pascarella,
- A. Lico,
- R. Paolini,
- N. Rabassi,
- N. Pescosta,
- M. Porrazzo,
- G. De Sabbata,
- A. Pompa,
- G. Bega,
- S. Cavallin,
- F. Guidotti,
- G. Semenzato,
- C. Zaina,
- F. Gherlinzoni
Affiliations
- A. Furlan
- 1 Hematology Unit, Azienda ULSS2 Marca Trevigiana, Treviso, Italy
- M. Cea
- 2 Hematology Unit, Department of Internal Medicine (DiMI), University of Genoa, IRCSS Ospedale Policlinico San Martino, Genova, Italy
- R. Zambello
- 3 Padua University School of Medicine, Hematology and Clinical Immunology, Padova, Italy
- L. Pavan
- 3 Padua University School of Medicine, Hematology and Clinical Immunology, Padova, Italy
- M Galli
- 4 Hematology Division, Ospedale Papa Giovanni XXIII, Bergamo, Italy
- C. Clissa
- 5 Hematology Unit and Stem Cells Transplant Center, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy
- S. Mangiacavalli
- 6 Hematology Division, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy
- A. Cafro
- 7 Hematology Unit, ASST GOM Niguarda, Milano, Italy
- S. Girlanda
- 8 Medical Oncology and Hematology Unit, ASST Fatebenefratelli Sacco, PO Fatebenefratelli, Milano, Italy
- F. Patriarca
- 9 Hematology Unit, Azienda Sanitaria Universitaria Friuli Centrale, DAME, Udine University School of Medicine, Udine, Italy
- C. Minotto
- 10 Medical Oncology and Hematology Unit, Azienda ULSS 3 Serenissima, Mirano, Italy
- G. Bertoldero
- 10 Medical Oncology and Hematology Unit, Azienda ULSS 3 Serenissima, Mirano, Italy
- G. Barilà
- 11 Hematology Unit, Azienda ULSS3 Serenissima, Ospedale dell’Angelo, Venezia-Mestre, Italy
- A. Pascarella
- 11 Hematology Unit, Azienda ULSS3 Serenissima, Ospedale dell’Angelo, Venezia-Mestre, Italy
- A. Lico
- 12 Hematology Unit, Azienda ULSS8 Berica, Ospedale San Bortolo, Vicenza, Italy
- R. Paolini
- 13 Hematology Unit, Ospedale Santa Maria della Misericordia, Rovigo, Italy
- N. Rabassi
- 14 Hematology Unit and Stem Cells Transplant Center, Ospedale Provinciale Bolzano, Bolzano, Italy
- N. Pescosta
- 14 Hematology Unit and Stem Cells Transplant Center, Ospedale Provinciale Bolzano, Bolzano, Italy
- M. Porrazzo
- 15 Hematology Unit, Ospedale Maggiore, Trieste, Italy
- G. De Sabbata
- 15 Hematology Unit, Ospedale Maggiore, Trieste, Italy
- A. Pompa
- 16 Hematology Unit, IRCCS Fondazione Ca’ Granda, Ospedale Maggiore Policlinico, Milano, Italy
- G. Bega
- 17 Medical Oncology Unit, Ospedale G. Fracastoro, Azienda ULSS 9 Scaligera, Verona, Italy
- S. Cavallin
- 18 Medical Oncology Unit, Ospedale di Vittorio Veneto, Azienda ULSS 2 Marca Trevigiana, Vittorio Veneto, Italy
- F. Guidotti
- 19 Division of Hematology, Department of Medicine, Ospedale Valduce, Como, Italy
- G. Semenzato
- 3 Padua University School of Medicine, Hematology and Clinical Immunology, Padova, Italy
- C. Zaina
- 1 Hematology Unit, Azienda ULSS2 Marca Trevigiana, Treviso, Italy
- F. Gherlinzoni
- 1 Hematology Unit, Azienda ULSS2 Marca Trevigiana, Treviso, Italy
- DOI
- https://doi.org/10.1097/01.HS9.0000936324.92381.77
- Journal volume & issue
-
Vol. 7,
no. S2
pp. 37 – 38
Abstract
No abstracts available.
